The Nevyas Drape Support is the simple and inexpensive way to establish a zone of comfort for your patients during ophthalmic surgery which requires draping over the nose and mouth. Packaged in sets
The Multi-Cap system provides patients with the ability to quickly change from distance viewing to reading. The telescope has a magnification of 1.75x for distance viewing. The double lens caps are
The longer working distances achieved by the use of Galilean optics make this the perfect magnifier to enable the patient to read and write.
The Redi-glaze spectacle magnifier is an aspheric lens, glazed into a standard Keeler LVA frame.
Medicine Products:(Date:12/3/2008)... ECPI College of Technology ...South Carolina veterans who have served in Iraq or...ly introduced in fall 2005 and is also available t...have served in these regions. Up to $150,000 in sc...sses at ECPI College of Technology or Medical Care...
(Date:12/3/2008)...CAGO, Dec. 3 The Americ...Institute of Medicine (IOM) for its committee repo...ember 2, 2008, by the IOM Committee on Optimizing ... Schedules to Improve Patient Safety. , , ...rther reductions in the mandated 80-hour work week...
(Date:12/3/2008)...CAGO, Dec. 3 Breast-Specific Gamma...tter specificity than breast MRI in patients with,...sound in the diagnosis of,breast cancer, accordin...g of,the Radiological Society of North America (R...e used as an adjunctive tool to mammography that c...
(Date:12/3/2008)...dy suggests need to change therapeutic guidelines,...s) -- A pill that contains two blood pressure drug...y in reducing the risk of serious cardiovascular p...re, according to a study that included more than 1...y, Denmark and Finland. , The patients took eit...
Breaking Medicine News(10 mins):Health News: ECPI College of Technology and Medical Careers Institute Announce Extension for South Carolina Military Scholarship Opportunity 2Health News:American College of Surgeons Comments on Institute of Medicine Report on Resident Duty Hours 2Health News:Molecular Breast Imaging Outperforms MRI for Patients With Inconclusive Results in the Diagnosis of Cancer 2Health News:Blood Pressure Pill Combo More Effective Than Diuretics 2(Date:12/2/2008).... 2 Biopure Corporation,...aval Medical Research Center,(NMRC) has submitted...ed,investigational new drug (IND) application to ...therapeutic Hemopure(R) [hemoglobin glutamer - 250...ment of trauma patients. The study is,entitled "O...
(Date:12/2/2008)... Horizon Therapeutics, Inc., a,pri...nced that two pivotal,Phase 3 trials evaluating i...,met all primary endpoints. HZT-501, a novel, pr...ng ibuprofen and famotidine, demonstrated a,stati... non-steroidal,anti-inflammatory drug (NSAID)-ind...
(Date:12/1/2008)...CAGO, Dec. 2 A study ha...a new technique for imaging the breast, is not aff...al status, two factors that limit the effectivenes...cer. Results will be presented today at the annual...ica (RSNA). , , "The ability of PEM to det...
(Date:12/1/2008)...Newswire/ -- S*BIO Pte Ltd today announced the ini... potent and orally-active JAK2 inhibitor, in leadi...chronic idiopathic myelofibrosis (CIMF). , ,...d tolerability of SB1518 in patients with CIMF and...e 1 part of the study will assess the safety profi...
Breaking Medicine Technology:U.S. Naval Medical Research Center Resubmits IND Application for Proposed 'Op RESUS' Clinical Trial in Trauma Patients in the Battlefield Setting 2U.S. Naval Medical Research Center Resubmits IND Application for Proposed 'Op RESUS' Clinical Trial in Trauma Patients in the Battlefield Setting 3Horizon Therapeutics Announces Two Pivotal HZT-501 Phase 3 Trials Meet Primary Endpoints 2Horizon Therapeutics Announces Two Pivotal HZT-501 Phase 3 Trials Meet Primary Endpoints 3Horizon Therapeutics Announces Two Pivotal HZT-501 Phase 3 Trials Meet Primary Endpoints 4New Mammography Technology Effective in Detecting Breast Cancer 2New Mammography Technology Effective in Detecting Breast Cancer 3New Mammography Technology Effective in Detecting Breast Cancer 4S*BIO Advances JAK2 Inhibitor SB1518 into Phase 1/2 Clinical Trial in Australia for the Treatment of Chronic Idiopathic Myelofibrosis 2S*BIO Advances JAK2 Inhibitor SB1518 into Phase 1/2 Clinical Trial in Australia for the Treatment of Chronic Idiopathic Myelofibrosis 3FDA Sunscreen Labeling Decision Delayed Another Month Leading U S Physician to Say Enough Is Enough 7225 1FDA Sunscreen Labeling Decision Delayed Another Month Leading U S Physician to Say Enough Is Enough 7225 2Sumitomo Corporation Appoints New Chairman to U S Animal Healthcare Company Summit VetPharm LLC 7223 1Sumitomo Corporation Appoints New Chairman to U S Animal Healthcare Company Summit VetPharm LLC 7223 2Sumitomo Corporation Appoints New Chairman to U S Animal Healthcare Company Summit VetPharm LLC 7223 3Sumitomo Corporation Appoints New Chairman to U S Animal Healthcare Company Summit VetPharm LLC 7223 4Sumitomo Corporation Appoints New Chairman to U S Animal Healthcare Company Summit VetPharm LLC 7223 5Neptune Technologies 26 Bioressources Inc Secures Access to Nationwide Consumer Mass Market in the United States 2013 1Neptune Technologies 26 Bioressources Inc Secures Access to Nationwide Consumer Mass Market in the United States 2013 2Neptune Technologies 26 Bioressources Inc Secures Access to Nationwide Consumer Mass Market in the United States 2013 3Caliper Life Sciences to Participate in Deutsche Banks Healthcare Technology Industry Day 2011 1... announced today,that Lipitor (atorvastatin calciu...ary heart disease events and major coronary events...nary heart disease,but who had experienced a recen...e results are from a new analysis of the landmark,...sterol Levels,(SPARCL) trial, and were presented a...
...s Demonstrates,Public Health Threat; Colonization ...Facility Units, SAN JOSE, Calif., June 25, 2007 /P...ssionals in Infection Control and Epidemiology,(AP...de study of,1,237 U.S. healthcare facilities, exam...hylococcus aureus (MRSA), a virulent,multi-drug re...
Other Medicine Technology:Lipitor Reduced the Risk of Coronary Events by Half and Stroke by,Nearly One-Third in High-Risk Patients with Type 2 Diabetes Who,Experienced a Recent Stroke 2Lipitor Reduced the Risk of Coronary Events by Half and Stroke by,Nearly One-Third in High-Risk Patients with Type 2 Diabetes Who,Experienced a Recent Stroke 3Largest National U.S. Healthcare Facility MRSA Study Reveals,Infection Rates Eight Times Greater Than Previous Estimates 2Largest National U.S. Healthcare Facility MRSA Study Reveals,Infection Rates Eight Times Greater Than Previous Estimates 3